Denmark’s Zealand Pharma Places Stalking Horse Bid on ValeritasBiotechnology, Blood Sugar Control, Breakthrough Device Designation, Business, Chapter 11 Bankruptcy, FDA, Gastrointestinal Diseases, Medical Devices, Metabolic Diseases, Specialty Diseases, Stalking Horse BidCopenhagen-based Zealand Pharma announced a bid to buy substantially all the assets from New Jersey-based Valeritas in $23 million in cash and taking on certain liabilities. Read more February 10, 2020/by BioSpace https://www.pharmalive.com/wp-content/uploads/2020/02/Zealand-Pharma-Stalking-Bid-BioSpace-2-10-20.jpeg 350 625 BioSpace https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png BioSpace2020-02-10 09:59:582020-02-10 22:59:39Denmark’s Zealand Pharma Places Stalking Horse Bid on Valeritas